Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2015, Article ID 816364, 6 pages
http://dx.doi.org/10.1155/2015/816364
Review Article

A Review on Pharmacological Properties of Zingerone (4-(4-Hydroxy-3-methoxyphenyl)-2-butanone)

1Molecular Biology Lab, Division of Veterinary Biochemistry, Faculty of Veterinary Sciences & Animal Husbandry, Sher-e-Kashmir University of Agricultural Science & Technology (SKUAST-K), Srinagar, Jammu and Kashmir 190006, India
2Forest Biotech Lab, Department of Forest Management, Faculty of Forestry, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
3Division of Livestock Production & Management, Faculty of Veterinary Sciences & Animal Husbandry, Sher-e-Kashmir University of Agricultural Science & Technology (SKUAST-K), Srinagar, Jammu and Kashmir 190006, India

Received 26 March 2015; Accepted 18 April 2015

Academic Editor: Thomas Efferth

Copyright © 2015 Bilal Ahmad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. J. Park and J. M. Pezzuto, “Botanicals in cancer chemoprevention,” Cancer and Metastasis Reviews, vol. 21, no. 3-4, pp. 231–255, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. Y.-X. Zhang, J.-S. Li, L.-H. Chen, W.-W. Peng, and B.-C. Cai, “Simultaneous determination of five gingerols in raw and processed ginger by HPLC,” Chinese Pharmaceutical Journal, vol. 47, no. 6, pp. 471–474, 2012. View at Google Scholar · View at Scopus
  3. W. J. Cotton, “Production of zingerone,” Google Patents, 1945.
  4. M. Takizawa, M. Sato, H. Kusuoku, and M. Sakasai, “Lipolysis stimulator,” Google Patents, 2012.
  5. I. Rajan, N. Narayanan, R. Rabindran, P. R. Jayasree, and P. R. Manish Kumar, “Zingerone protects against stannous chloride-induced and hydrogen peroxide-induced oxidative DNA damage in vitro,” Biological Trace Element Research, vol. 155, no. 3, pp. 455–459, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. M. K. Kim, S. W. Chung, J. M. Kim et al., “Modulation of age-related NF-κB activation by dietary zingerone via MAPK pathway,” Experimental Gerontology, vol. 45, no. 6, pp. 419–426, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Vinothkumar, M. Sudha, and N. Nalini, “Chemopreventive effect of zingerone against colon carcinogenesis induced by 1,2-dimethylhydrazine in rats,” European Journal of Cancer Prevention, vol. 23, no. 5, pp. 361–371, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Kumar, S. Chhibber, and K. Harjai, “Zingerone inhibit biofilm formation and improve antibiofilm efficacy of ciprofloxacin against Pseudomonas aeruginosa PAO1,” Fitoterapia, vol. 90, pp. 73–78, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. D. V. Rajakumar and M. N. A. Rao, “Dehydrozingerone and its analogues as inhibitors of nonenzymatic lipid peroxidation,” Pharmazie, vol. 49, no. 7, pp. 516–519, 1994. View at Google Scholar · View at Scopus
  10. D. Banji, O. J. F. Banji, B. Pavani, C. Kranthi Kumar, and A. R. Annamalai, “Zingerone regulates intestinal transit, attenuates behavioral and oxidative perturbations in irritable bowel disorder in rats,” Phytomedicine, vol. 21, no. 4, pp. 423–429, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Vaibhav, P. Shrivastava, R. Tabassum et al., “Delayed administration of zingerone mitigates the behavioral and histological alteration via repression of oxidative stress and intrinsic programmed cell death in focal transient ischemic rats,” Pharmacology Biochemistry and Behavior, vol. 113, pp. 53–62, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. S.-G. Shin, Y. K. Ji, Y. C. Hae, and J.-C. Jeong, “Zingerone as an antioxidant against peroxynitrite,” Journal of Agricultural and Food Chemistry, vol. 53, no. 19, pp. 7617–7622, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. K. L. Hemalatha, P. Stanley, and M. Prince, “Antihyperlipidaemic, antihypertrophic and reducing effects of Zingerone on experimentally iso-proterenol induced myocardial infracted rats,” Journal of Biochemical and Molecular Toxicology, vol. 29, no. 4, pp. 182–188, 2015. View at Publisher · View at Google Scholar
  14. T. Emmanuel, B. Aristide, T. Leopold, N. M. Benoît, and M. T. Joseph, “Phytochemical screening, chemical composition and antimicrobial activity of Zingiber officinale essential oil of Adamaoua region (Cameroon),” Journal of Chemical and Pharmaceutical Research, vol. 5, no. 7, pp. 296–301, 2013. View at Google Scholar · View at Scopus
  15. E. McNeill and N. Hogg, “S100A9 has a protective role in inflammation-induced skin carcinogenesis,” International Journal of Cancer, vol. 135, no. 4, pp. 798–808, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Kabuto and T. T. Yamanushi, “Effects of zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] and eugenol [2-methoxy-4-(2-propenyl)phenol] on the pathological progress in the 6-hydroxydopamine-induced parkinson's disease mouse model,” Neurochemical Research, vol. 36, no. 12, pp. 2244–2249, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Kabuto, M. Nishizawa, M. Tada, C. Higashio, T. Shishibori, and M. Kohno, “Zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] prevents 6-hydroxydopamine-induced dopamine depression in mouse striatum and increases superoxide scavenging activity in serum,” Neurochemical Research, vol. 30, no. 3, pp. 325–332, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. S. W. Chung, M. K. Kim, J. H. Chung et al., “Peroxisome proliferator-activated receptor activation by a short-term feeding of zingerone in aged rats,” Journal of Medicinal Food, vol. 12, no. 2, pp. 345–350, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. C.-Y. Hsiang, H.-Y. Lo, H.-C. Huang, C.-C. Li, S.-L. Wu, and T.-Y. Ho, “Ginger extract and zingerone ameliorated trinitrobenzene sulphonic acid-induced colitis in mice via modulation of nuclear factor-κB activity and interleukin-1β signalling pathway,” Food Chemistry, vol. 136, no. 1, pp. 170–177, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Kumar, S. Chhibber, and K. Harjai, “Hepatoprotective effect of zingerone (4-(4-hydroxy-3-methoxyphenyl) butan-2-one) in lipopolysaccharide induced liver injury mouse model through down regulation of inflammatory mediators,” International Journal of Pharmacognosy and Phytochemical Research, vol. 6, no. 2, pp. 308–314, 2014. View at Google Scholar
  21. J.-C. Chen, L.-J. Huang, S.-L. Wu, S.-C. Kuo, T.-Y. Ho, and C.-Y. Hsiang, “Ginger and its bioactive component inhibit enterotoxigenic Escherichia coli heat-labile enterotoxin-induced diarrhea in mice,” Journal of Agricultural and Food Chemistry, vol. 55, no. 21, pp. 8390–8397, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Iwami, T. Shiina, H. Hirayama, T. Shima, T. Takewaki, and Y. Shimizu, “Inhibitory effects of zingerone, a pungent component of Zingiber officinale Roscoe, on colonic motility in rats,” Journal of Natural Medicines, vol. 65, no. 1, pp. 89–94, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Liu, J. M. Welch, R. P. Erickson, P. H. Reinhart, and S. A. Simon, “Different responses to repeated applications of zingerone in behavioral studies, recordings from intact and cultured TG neurons, and from VR1 receptors,” Physiology & Behavior, vol. 69, no. 1, pp. 177–186, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Bratton, P. A. S. Johnstone, and K. P. McMullen, “Outpatient management of vascular access devices in children receiving radiotherapy: complications and morbidity,” Pediatric Blood & Cancer, vol. 61, no. 3, pp. 499–501, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. B. N. Rao, B. S. S. Rao, B. K. Aithal, and M. R. S. Kumar, “Radiomodifying and anticlastogenic effect of Zingerone on Swiss albino mice exposed to whole body gamma radiation,” Mutation Research/Genetic Toxicology and Environmental Mutagenesis, vol. 677, no. 1-2, pp. 33–41, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Motohashi, Y. Ashihara, C. Yamagami, and Y. Saito, “Antimutagenic effects of dehydrozingerone and its analogs on UV-induced mutagenesis in Escherichia coli,” Mutation Research—Fundamental and Molecular Mechanisms of Mutagenesis, vol. 377, no. 1, pp. 17–25, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. L. J. Buccellato, M. Tso, O. I. Akinci, N. S. Chandel, and G. R. S. Budinger, “Reactive oxygen species are required for hyperoxia-induced Bax activation and cell death in alveolar epithelial cells,” The Journal of Biological Chemistry, vol. 279, no. 8, pp. 6753–6760, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Cory and J. M. Adams, “The BCL2 family: regulators of the cellular life-or-death switch,” Nature Reviews Cancer, vol. 2, no. 9, pp. 647–656, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. M. B. Sporn, “Approaches to prevention of epithelial cancer during the preneoplastic period,” Cancer Research, vol. 36, no. 7, pp. 2699–2702, 1976. View at Google Scholar · View at Scopus
  30. B. B. Aggarwal and S. Shishodia, “Molecular targets of dietary agents for prevention and therapy of cancer,” Biochemical Pharmacology, vol. 71, no. 10, pp. 1397–1421, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. Y.-J. Surh, “Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 428, no. 1-2, pp. 305–327, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. Y.-J. Surh, “Cancer chemoprevention with dietary phytochemicals,” Nature Reviews Cancer, vol. 3, no. 10, pp. 768–780, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. A. K. Pillai, K. K. Sharma, Y. K. Gupta, and S. Bakhshi, “Anti-emetic effect of ginger powder versus placebo as an add-on therapy in children and young adults receiving high emetogenic chemotherapy,” Pediatric Blood & Cancer, vol. 56, no. 2, pp. 234–238, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. J. L. Ryan, C. E. Heckler, J. A. Roscoe et al., “Ginger reduces acute chemotherapy induced nausea: a URCCCCOP study of 576 patients,” Support Care Cancer, vol. 20, pp. 1479–1489, 2012. View at Google Scholar
  35. Z. Jin, G. Lee, S. Kim, C.-S. Park, Y. S. Park, and Y.-H. Jin, “Ginger and its pungent constituents non-competitively inhibit serotonin currents on visceral afferent neurons,” The Korean Journal of Physiology & Pharmacology, vol. 18, no. 2, pp. 149–153, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. S. S. Sharma, V. Kochupillai, S. K. Gupta, S. D. Seth, and Y. K. Gupta, “Antiemetic efficacy of ginger (Zingiber officinale) against cisplatin-induced emesis in dogs,” Journal of Ethnopharmacology, vol. 57, no. 2, pp. 93–96, 1997. View at Publisher · View at Google Scholar · View at Scopus
  37. World Health Organization, “Obesity preventing and managing the global epidemic, report of a WHO consultation,” WHO Technical Report Series 894, WHO, 2000. View at Google Scholar
  38. R. M. Pinder, R. N. Brogden, P. R. Sawyer, T. M. Speight, and G. S. Avery, “Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity,” Drugs, vol. 10, no. 4, pp. 241–323, 1975. View at Publisher · View at Google Scholar · View at Scopus
  39. F. Brenot, P. Herve, P. Petitpretz, F. Parent, P. Duroux, and G. Simonneau, “Primary pulmonary hypertension and fenfluramine use,” British Heart Journal, vol. 70, no. 6, pp. 537–541, 1993. View at Publisher · View at Google Scholar · View at Scopus
  40. J. P. Park, J. H. Kim, M. K. Park, and J. W. Yun, “Potential agents for cancer and obesity treatment with herbal medicines from the green garden,” Biotechnology and Bioprocess Engineering, vol. 16, no. 6, pp. 1065–1076, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. B. A. Swinburn, I. Caterson, J. C. Seidell, and W. P. T. James, “Diet, nutrition and the prevention of excess weight gain and obesity,” Public Health Nutrition, vol. 7, no. 1A, pp. 123–146, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. K. A. Amin and M. A. Nagy, “Effect of Carnitine and herbal mixture extract on obesity induced by high fat diet in rats,” Diabetology & Metabolic Syndrome, vol. 1, article 17, 14 pages, 2009. View at Publisher · View at Google Scholar
  43. L.-K. Han, C. Morimoto, Y.-N. Zheng et al., “Effects of zingerone on fat storage in ovariectomized rats,” Yakugaku Zasshi, vol. 128, no. 8, pp. 1195–1201, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Thunchomnang, K. Lawa, A. Mangkhalathon, P. Saenubol, S. Rattanakiat, and P. Pulbutr, “Lipolytic effects of zingerone in isolated rat adipocytes,” in Proceedings of the 4th Annual Northeast Pharmacy Research Conference, 2012.